1. Home
  2. NYAX vs RARE Comparison

NYAX vs RARE Comparison

Compare NYAX & RARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nayax Ltd.

NYAX

Nayax Ltd.

HOLD

Current Price

$66.80

Market Cap

2.3B

Sector

N/A

ML Signal

HOLD

Logo Ultragenyx Pharmaceutical Inc.

RARE

Ultragenyx Pharmaceutical Inc.

HOLD

Current Price

$23.47

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NYAX
RARE
Founded
2005
2010
Country
Israel
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.1B
IPO Year
2022
2013

Fundamental Metrics

Financial Performance
Metric
NYAX
RARE
Price
$66.80
$23.47
Analyst Decision
Buy
Strong Buy
Analyst Count
4
20
Target Price
$49.50
$59.10
AVG Volume (30 Days)
47.0K
1.6M
Earning Date
05-12-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
7.31
EPS
N/A
N/A
Revenue
N/A
$673,000,000.00
Revenue This Year
$30.66
$13.12
Revenue Next Year
$21.70
$37.80
P/E Ratio
$89.78
N/A
Revenue Growth
N/A
20.13
52 Week Low
$38.50
$18.29
52 Week High
$75.00
$40.17

Technical Indicators

Market Signals
Indicator
NYAX
RARE
Relative Strength Index (RSI) 51.00 42.71
Support Level $51.53 $22.00
Resistance Level $74.83 $23.44
Average True Range (ATR) 2.52 1.17
MACD -0.96 -0.42
Stochastic Oscillator 31.58 21.97

Price Performance

Historical Comparison
NYAX
RARE

About NYAX Nayax Ltd.

Nayax Ltd is an end-to-end retail technology platform for unattended commerce. It unifies payments, operations management, and customer engagement tools into a powerful, adaptable platform for modern commerce. It provides solutions that empower businesses to enhance customer experience, accept cashless payments, and manage their operations with a robust Internet of Things (IoT) software platform, helping achieve long-term growth. The company addresses a broad range of retail verticals, including all types of vending machines, coffee machines, unattended checkout counters, self-service kiosks, ticketing machines, car wash stations, gaming machines, amusement rides, laundromats, EV charging stations, and many more.

About RARE Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. The company identifies, acquires, develops, and commercializes novel products for the treatment of serious, rare, and ultra-rare diseases, with a focus on debilitating genetic conditions. Its medicine portfolio includes Crysvita, Dojolvi, and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients aged one year and older. Mepsevii is indicated for pediatric and adult patients for the treatment of Mucopolysaccharidosis VII. The company operates across North America, Latin America, Europe, the Middle East and Africa, and Asia-Pacific, with the majority of its revenue generated from North America.

Share on Social Networks: